1,040 results on '"Moorman A. V."'
Search Results
2. Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction
3. ETV6::RUNX1 Acute Lymphoblastic Leukemia: how much therapy is needed for cure?
4. Combination p53 activation and BCL-xL/BCL-2 inhibition as a therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia
5. Real-world evaluation of UK high hyperdiploidy profile using a large cohort of patients provided by HARMONY data platform
6. Targeted treatment options for paediatric B-cell precursor acute lymphoblastic leukaemia patients with constitutional or somatic chromosome 21 alterations
7. A robust and validated integrated prognostic index for defining risk groups in adult acute lymphoblastic leukemia: an EWALL collaborative study
8. Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia
9. Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trial
10. Disruption to the FOXO-PRDM1 axis resulting from deletions of chromosome 6 in acute lymphoblastic leukaemia
11. Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemia
12. Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working Group
13. The genomic landscape of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21
14. Diagnostic utility of whole genome sequencing in adults with B-other acute lymphoblastic leukemia
15. Dasatinib with intensive chemotherapy in de novo paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (CA180-372/COG AALL1122): a single-arm, multicentre, phase 2 trial
16. EBV-driven lymphoid neoplasms associated with pediatric ALL maintenance therapy
17. Germline variants in predisposition genes in children with Down syndrome and acute lymphoblastic leukemia
18. A dedicated caller for DUX4 rearrangements from whole-genome sequencing data.
19. Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, randomised controlled trial
20. In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission: results from the prospective, single-arm evaluation of the UKALL14 trial
21. Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study
22. Results from UKALL60+, a phase 2 study in older patients with untreated acute lymphoblastic leukemia
23. DNA-thioguanine concentration and relapse risk in children and young adults with acute lymphoblastic leukemia: an IPD meta-analysis
24. Prognostic value of Oncogenetic mutations in pediatric T Acute Lymphoblastic Leukemia: a comparison of UKALL2003 and FRALLE2000T protocols
25. Defining low-risk high hyperdiploidy in patients with paediatric acute lymphoblastic leukaemia: a retrospective analysis of data from the UKALL97/99 and UKALL2003 clinical trials
26. Minimal residual disease, long-term outcome, and IKZF1 deletions in children and adolescents with Down syndrome and acute lymphocytic leukaemia: a matched cohort study
27. Molecular classification improves risk assessment in adult BCR-ABL1–negative B-ALL
28. IKZF1 alterations are not associated with outcome in 498 adults with B-precursor ALL enrolled in the UKALL14 trial
29. Risk factors and outcomes in children with high-risk B-cell precursor and T-cell relapsed acute lymphoblastic leukaemia: combined analysis of ALLR3 and ALL-REZ BFM 2002 clinical trials
30. Clinical characteristics and outcomes of B-ALL with ZNF384 rearrangements: a retrospective analysis by the Ponte di Legno Childhood ALL Working Group
31. Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort study
32. DNA-TG and risk of sinusoidal obstruction syndrome in childhood acute lymphoblastic leukemia
33. A validated novel continuous prognostic index to deliver stratified medicine in pediatric acute lymphoblastic leukemia
34. Pelops: A dedicated caller for DUX4 rearrangements from whole-genome sequencing data
35. Noncoding mutations drive persistence of a founder preleukemic clone which initiates late relapse in T-ALL
36. Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia.
37. IKZF1 deletions in pediatric acute lymphoblastic leukemia: still a poor prognostic marker?
38. Results from UKALL60+,:a phase 2 study in older patients with untreated acute lymphoblastic leukemia
39. Outcomes of patients with childhood B-cell precursor acute lymphoblastic leukaemia with late bone marrow relapses: long-term follow-up of the ALLR3 open-label randomised trial
40. Validation of the United Kingdom copy-number alteration classifier in 3239 children with B-cell precursor ALL
41. Targeted treatment options for paediatric B-cell precursor acute lymphoblastic leukaemia patients with constitutional or somatic chromosome 21 alterations
42. Acute lymphoblastic leukaemia
43. International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia
44. SH2B3 inactivation through CN-LOH 12q is uniquely associated with B-cell precursor ALL with iAMP21 or other chromosome 21 gain
45. Correction: The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALL
46. Cytogenetics and Molecular Genetics
47. Blinatumomab for First-Line Treatment of Children and Young Persons With B-ALL
48. Cranial radiotherapy has minimal benefit in children with central nervous system involvement in T-ALL
49. ETV6::RUNX1Acute Lymphoblastic Leukemia: how much therapy is needed for cure?
50. Intragenic amplification of PAX5: a novel subgroup in B-cell precursor acute lymphoblastic leukemia?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.